Levetiracetam: the first SV2A ligand for the treatment of epilepsy

Author: Klitgaard Henrik   Verdru Peter  

Publisher: Informa Healthcare

ISSN: 1746-0441

Source: Expert Opinion on Drug Discovery, Vol.2, Iss.11, 2007-11, pp. : 1537-1545

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract